Clinical and Diagnostic Laboratory Immunology, January 1999, p. 140-141, Vol. 6, No. 1
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Pathology and Laboratory Medicine, Summa Health System, Akron, Ohio 443041; Northeastern Universities College of Medicine, Rootstown, Ohio 442722; and Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 441063
Received 5 March 1998/Returned for modification 27 May 1998/Accepted 4 November 1998
Prenatal human immunodeficiency virus (HIV) screening may reduce vertical HIV transmission. We screened 4,419 prenatal sera and found 38 repeatedly reactive specimens with an HIV-1-HIV-2 enzyme-linked immunosorbent assay. Western blot analysis confirmed four of these specimens as positive for HIV-1 antibodies. Screening detects previously unidentified HIV infections, but false-positive results may also occur.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |